187 related articles for article (PubMed ID: 14641270)
1. Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema.
Karacorlu M; Ozdemir H; Karacorlu S
Acta Ophthalmol Scand; 2003 Dec; 81(6):648-52. PubMed ID: 14641270
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results.
Boscia F; Furino C; Dammacco R; Ferreri P; Sborgia L; Sborgia C
Eur J Ophthalmol; 2005; 15(1):89-95. PubMed ID: 15751245
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Ozdemir H; Karacorlu M; Karacorlu S
Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
[TBL] [Abstract][Full Text] [Related]
4. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone for refractory pseudophakic macular edema.
Benhamou N; Massin P; Haouchine B; Audren F; Tadayoni R; Gaudric A
Am J Ophthalmol; 2003 Feb; 135(2):246-9. PubMed ID: 12566041
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.
Dong Z; Namba K; Kitaichi N; Goda C; Kitamura M; Ohno S
Jpn J Ophthalmol; 2008; 52(5):374-379. PubMed ID: 18991038
[TBL] [Abstract][Full Text] [Related]
9. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema.
Jonas JB; Kreissig I; Degenring RF
Am J Ophthalmol; 2003 Aug; 136(2):384-6. PubMed ID: 12888077
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Park CH; Jaffe GJ; Fekrat S
Am J Ophthalmol; 2003 Sep; 136(3):419-25. PubMed ID: 12967793
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.
Atmaca LS; Yalçindağ FN; Ozdemir O
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):451-6. PubMed ID: 17226025
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone for refractory diabetic macular edema.
Martidis A; Duker JS; Greenberg PB; Rogers AH; Puliafito CA; Reichel E; Baumal C
Ophthalmology; 2002 May; 109(5):920-7. PubMed ID: 11986098
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
Sørensen TL; Haamann P; Villumsen J; Larsen M
Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
18. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion.
Karacorlu M; Ozdemir H; Karacorlu SA
Retina; 2005; 25(7):856-60. PubMed ID: 16205564
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema.
Avci R; Kaderli B; Akalp FD
Clin Exp Ophthalmol; 2006; 34(1):27-32. PubMed ID: 16451255
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema.
Sevim MS; Sanisoglu H; Turkyilmaz K
Curr Eye Res; 2012 Dec; 37(12):1165-70. PubMed ID: 22928501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
